Weight-loss treatment
Articles on clinician-led weight management for men: who may be eligible, how a clinician assesses and reviews you, what to expect week by week, and how to choose or switch provider. The service itself is described on the medical weight loss page. Whether treatment is right for you is a clinical decision.
-
Blood test first or questionnaire alone: how UK online weight management services differ
The pharmacy regulator says a questionnaire alone is not enough for weight management prescribing. How a blood-test-first service differs, and what to ask.
-
Does a structured programme help you take weight-loss medication as prescribed?
In other conditions, reminders roughly doubled the odds of taking medicine as prescribed, and most people on two UK programmes stayed on treatment.
-
How long do you stay on Wegovy? Maintenance, pausing and stopping: what the licence and the trials say
No end date: the licence names weight maintenance as part of treatment and sets one 6-month review. What that means for staying on, pausing or stopping.
-
Switching to the Wegovy pill: what the licence says about moving from another provider or from the injection
Moving to the tablet from another provider or another form: what the UK licence says, what a new prescriber reviews and what changes in your routine.
-
Weight-loss treatment timelines for men: the licensed dose schedules of Wegovy, the Wegovy pill, Mounjaro and Foundayo, month by month
Four weight-management medicines, month by month: where each UK licence starts, the shortest time it allows at each step and where each schedule ends.
-
Wegovy for men vs women: does the response differ?
On average, women lost more weight than men on Wegovy in the trials. The data for men, the likely reasons, and why an average is not a prediction.
-
Foundayo for men: what to expect week by week, from the starting dose to maintenance
Foundayo (orforglipron) week by week: the six dose steps from 0.8 mg to 17.2 mg, no food or water rules, side effects and when to call your clinician.
-
Eating well on a GLP-1 weight-loss medicine: protein, fluids and smaller meals
What NHS dietitians advise for eating on a GLP-1 weight-loss medicine: smaller meals, protein at each meal, fluids, fibre and the foods that worsen nausea.
-
The Wegovy pill for men: what to expect week by week, from the starting dose to maintenance
The Wegovy pill (oral semaglutide) week by week: the four dose steps, the empty-stomach rule, when side effects ease and when to call your clinician.
-
Wegovy injection for men: what to expect week by week, from the starting dose to maintenance
The Wegovy injection week by week: the four dose steps to 2.4 mg, the optional 7.2 mg dose, when side effects ease and when to call your clinician.
-
Mounjaro for men: what to expect week by week, from the starting dose to maintenance
What to expect on Mounjaro (tirzepatide) week by week: the dose steps, when appetite changes, when side effects ease, and when to contact your clinician.
-
Am I eligible for medical weight loss treatment? How a UK clinician decides
Who is eligible for medical weight loss treatment in the UK, who decides, what a clinician checks before prescribing and what happens if the answer is no.
-
Weight loss programmes for men: what to look for in 2026
A checklist for judging any clinician-led weight management programme: blood testing, who reviews results, retesting, the fee and the NHS route.
-
GP or online clinician-led weight management: which is right for you?
How the NHS weight management pathway works, what a private online clinician-led programme offers, the honest limits of each, and how to decide.
-
Mounjaro hair loss in men: causes, timeline, and what you can do
Hair loss on Mounjaro is far less common in men than women. Here's what the trial data shows, the typical timeline, and how to support regrowth.
-
Mounjaro face in men: what facial changes to expect during weight loss
"Mounjaro face" is facial change from fat loss, not the drug. What men should expect, why it happens, and how protein and pacing help.
-
How to switch to HeMed from another weight loss programme
Thinking of switching weight loss programmes? How the HeMed switch works for men - eligibility, at-home blood test, and ongoing clinical monitoring.
-
Does Mounjaro affect male fertility? What the current evidence shows
Does Mounjaro affect male fertility? What the current animal and human evidence shows - and what to discuss with a clinician before starting treatment.
-
Orforglipron (Foundayo): what the MHRA licence means and what the trials showed
Orforglipron (Foundayo) is a tablet licensed by the MHRA in August 2026. How it works for men, what the trials reported and its side effects.
-
Mounjaro results for men: what the clinical trials show month by month
What Mounjaro results look like for men month by month, based on clinical trial data, with realistic timelines and what changes beyond the scales.
-
Wegovy results for men at each dose stage: what the trials show
How men's weight loss on Wegovy builds from the starting dose to maintenance: what the clinical evidence shows at each stage and why results vary.
-
Wegovy vs Mounjaro for men: how the two compare
Wegovy vs Mounjaro for men: how the two injections differ, what the SURMOUNT-5 head-to-head trial found, and the side effects to expect.
-
Mounjaro and alcohol: what you actually need to know
Can you drink alcohol on Mounjaro? We cover the real risks, how it affects your progress, timing guidance and research on cravings.
-
How the Wegovy pill works for men: oral semaglutide explained
How the Wegovy pill (oral semaglutide) works for men, what the OASIS 4 trial reported and the side effects to expect.
-
Retatrutide: what the Phase 3 trials show and why it is not available in the UK
Retatrutide is an investigational triple agonist in Phase 3 trials. What the data shows, its side effects, and why it is not licensed in the UK.
-
MHRA licenses oral semaglutide for weight management: what was approved
The MHRA has licensed oral semaglutide (the Wegovy pill) for weight management. What was approved, the OASIS 4 trial data, dosing and side effects.
-
Wegovy® 7.2mg: what this new higher dose means for you
Wegovy 7.2mg is a higher maintenance dose for people already established on 2.4mg. Who it may suit, how the step-up works and the safety points to know.
-
Wegovy for men in the UK: am I eligible?
Men may be prescribed Wegovy if they meet the UK licence criteria. The BMI thresholds, the weight-related conditions that count and who decides.
-
Mounjaro (tirzepatide) for men: how it works, evidence and safety
How Mounjaro (tirzepatide) works for men in the UK, what the SURMOUNT-1 trial reported, the common side effects and the safety information to know.
-
Wegovy (semaglutide): how it works, evidence and safety
A men's guide to Wegovy (semaglutide): how it works, what the clinical trials reported, and the side effects, risks and contraindications to know.
-
What is Mounjaro? A comprehensive guide for men
What Mounjaro (tirzepatide) is, what it is licensed to treat in the UK, how its dual GIP and GLP-1 action works, its dosing, side effects and safety.
